A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants
Clinical trial NCT06670950 · COMPLETED
Trial details
- NCT number
- NCT06670950
- Sponsor
- Synendos Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2025-05-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.